The novel ocular drug delivery devices market is projected to grow at a CAGR of 15%, till 2030, claims Roots Analysis

NEXT STORY
Sonic Incytes Showcases Velacur™ at ACG 2021
PREV STORY
Lost Generation: Pandemic School Closures Could Make Canada’s Skills Gap Much Worse
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting

PRESS RELEASE Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma ...

author_avatar
NASDAQ Market News

Esperite NV (ESP) with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the first-in-man clinical trials in treatment of Crohn’s disease.

Amsterdam, The Netherlands -17th May 2018 Esperite's The Cell Factory has signed today the agreement with ...

author_avatar
NASDAQ Market News

Acepodia Announces Expansion of Board of Directors and Scientific Advisory Board

author_avatar
NASDAQ Market News